Skip to main content

The FDA Advisory Committee noted this week, that people with cosmetic facial fillers could experience swelling and inflammation with Moderna’s coronavirus vaccines, based on the fact that several trial participants with fillers have already experienced side effects.

Claiming it to be an immunological reaction, medical expert Dr. Shirley Chi, who noted the side effects were easily treated by medical personnel, said, “Your immune system which causes inflammation is revved up when you get a vaccine, that’s how it’s supposed to work. So it makes sense that you would see an immune response in certain areas where they see some substance that is not a naturally occurring substance in your body.

This being said, the doctor also suggested that people with cosmetic fillers should not refrain from taking the vaccine, since that may hinder the overall building of a herd immunity that is needed to ward away the highly-infectious virus.

Source: Medical News Today

She went on to explain, “In these cases, the patients all had swelling and inflammation in the area that was given the filler. A couple of the patients had cheek filler six months prior to their vaccine and one patient had lip filler done two days after the vaccine. All were treated with steroids and anti-histamines and all of their reactions resolved.”

Although early results of large, still unfinished studies show both Pfizer and Moderna’s vaccines appear safe and strongly protective although, there are still reports of a few allergic reactions, which, through the course of time would be easier to tackle. 

Meanwhile, on Thursday, Dr. Moncef Slaoui, the chief scientific adviser for Operation Warp Speed said the frequency of allergic reactions to the Pfizer-BioNTech coronavirus vaccine is higher than what would be expected for other jabs.“That frequency, as it stood yesterday, is superior to what one would expect with other vaccines,” he said after a slew of more reactions were seen in the country on Tuesday.

Slaoui said discussions are underway between the vaccine makers and the National Institutes of Health to consider holding clinical trials of vaccines in very allergic populations, such as people who always have to carry anti-allergy medication in an EpiPen, in order to ensure its safety and efficacy. 

JOIN US ON WHAT'SAPP, TO GET INSTANT STATUS UPDATES AND BE IN THE KNOW.

CLICK HERE

Rhea Sovani

Author Rhea Sovani

More posts by Rhea Sovani

Leave a Reply